XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance, beginning of period at Dec. 31, 2017     $ 0.0          
Balance, end of period at Dec. 30, 2018     0.0          
Balance, beginning of period (in shares) at Dec. 31, 2017       103,300,000        
Balance, beginning of period at Dec. 31, 2017 $ 511.5 $ (0.2)   $ 0.0 $ 1,233.7 $ (1.4) $ (720.8) $ (0.2)
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation 7.2       7.2      
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)       400,000        
Issuance of common stock for employee stock purchase plan, options and warrants 3.7       3.7      
Restricted stock issued and related taxes (in shares)       100,000        
Restricted stock issued and related taxes (0.1)       (0.1)      
Pro forma net income attributable to Kratos (3.5)           (3.5)  
Other comprehensive income (loss), net of tax 0.7         0.7    
Balance, end of period (in shares) at Dec. 30, 2018       103,800,000        
Balance, end of period at Dec. 30, 2018 519.3     $ 0.0 1,244.5 (0.7) (724.5)  
Redeemable Noncontrolling Interest                
Net income (loss)     0.1          
Changes in noncontrolling interest     14.9          
Balance, end of period at Dec. 29, 2019     15.0          
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation 11.0       11.0      
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)       800,000        
Issuance of common stock for employee stock purchase plan, options and warrants 4.9       4.9      
Restricted stock issued and related taxes (in shares)       200,000        
Restricted stock issued and related taxes (0.9)       (0.9)      
Issuance of common stock for acquisitions (in shares)       1,800,000        
Issuance of common stock for acquisitions 27.0       27.0      
Pro forma net income attributable to Kratos 12.5           12.5  
Other comprehensive income (loss), net of tax $ 0.3         0.3    
Balance, end of period (in shares) at Dec. 29, 2019 106,635,508     106,600,000        
Balance, end of period at Dec. 29, 2019 $ 574.1     $ 0.0 1,286.5 (0.4) (712.0)  
Redeemable Noncontrolling Interest                
Net income (loss)     (0.2)          
Balance, end of period at Dec. 27, 2020     $ 14.8          
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation 21.0       21.0      
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)       400,000        
Issuance of common stock for employee stock purchase plan, options and warrants 4.8       4.8      
Restricted stock issued and related taxes (in shares)       200,000        
Restricted stock issued and related taxes (1.4)       (1.4)      
Issuance of common stock for acquisitions (in shares)       15,800,000        
Issuance of common stock for acquisitions 245.4       245.4      
Pro forma net income attributable to Kratos 79.6           79.6  
Other comprehensive income (loss), net of tax $ 1.8         1.8    
Balance, end of period (in shares) at Dec. 27, 2020 123,047,147     123,000,000.0        
Balance, end of period at Dec. 27, 2020 $ 925.3     $ 0.0 $ 1,556.3 $ 1.4 $ (632.4)